Targeted Drug Trastuzumab Deruxtecan Slows Growth of Metastatic Breast Cancer
Trastuzumab deruxtecan (Enhertu) is an example of targeted therapy for breast cancer. A new study of this targeted drug showed that in people with metastatic HR+ and HER2-low and ultra-low breast cancer, it can prevent the cancer from growing for a longer …